Zhaojun Lu

Zhaojun Lu

Auto-generated profile, based on publicly available information

Zhaojun Lu

Department of Public Health, Xuzhou Medical College, Xuzhou, Jiangsu, China

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 December 2013 in Journal of Gastroenterology and Hepatology
Verified
Journal Article
Closed access
PDF file
HWHui Wang
Hui Wang
GSGuixiang Sun
Guixiang Sun
PZPeijin Zhang
Peijin Zhang
JZJing Zhang
Jing Zhang
EGEr Gui
Er Gui
ZLZhaojun Lu
Zhaojun Lu

21 August 2014 in Angiology
Verified
Journal Article
Closed access
PZPeijin Zhang
Peijin Zhang
XGXiuyin Gao
Xiuyin Gao
YZYanyan Zhang
Yanyan Zhang
YHYuewen Hu
Yuewen Hu
HMHe Ma
He Ma
ZLZhaojun Lu
Zhaojun Lu
The association between methylenetetrahydrofolate reductase (MTHFR) gene polymorphisms and venous thromboembolism (VTE) risk in the Chinese population has been widely reported, but results were inconsistent and underpowered. To elucidate the variable results, a meta-analysis and systematic review were performed from all case-controlled studies relating MTHFR C677T polymorphism by pooling data on them. We estimated the pooled odds ratio with its 95% confidence intervals to assess this possible association. Finally, a total of 24 studies with 2339 cases and 4048 controls were included in the current meta-analysis. Significant association was found with VTE risk for all genetic models. Subgroup analyses by type of VTE further identified the above-mentioned association in deep vein thrombosis/pulmonary embolism and splanchnic vein thrombosis. The findings from our meta-analysis support the associations of MTHFR C677T polymorphism with VTE risk in the Chinese population.

22 April 2014 in PLOS ONE
Verified
Journal Article
Open access
PDF file
PZPeijin Zhang
Peijin Zhang
JZJing Zhang
Jing Zhang
GSGuixiang Sun
Guixiang Sun
XGXiuyin Gao
Xiuyin Gao
HWHui Wang
Hui Wang
ZLZhaojun Lu
Zhaojun Lu
Various studies have demonstrated that factor V Leiden (FVL) and G20210A prothrombin mutation contribute to the risk of Budd-Chiari syndrome (BCS), while other studies provided conflicting findings. In order to derive more precise estimations of the relationships, a meta-analysis was performed. Eligible articles were identified through search of databases including Pubmed, Chinese Biomedical Database (CBM, Chinese), and Chinese National Knowledge Infrastructure (CNKI, Chinese). Odd ratios (ORs) with 95% confidence intervals (CIs) were calculated using random- or fixed- model. Finally, twelve studies were included for FVL and nine studies were included for G20210A prothrombin mutation. With respect to FVL, significantly increased BCS risk was found in the overall population (OR = 6.29, 95%CI = 4.23–9.36). Subgroup analyses suggested that FVL was associated with an increased risk of BCS in the population with high background mutation prevalence (>1% in the normal population). No significant association was found between BCS and G20210A prothrombin mutation (OR = 1.78, 95%CI = 0.77–4.11). The presence of FVL should be evaluated in patients with BCS. Conversely, G20210A prothrombin mutation is not significantly associated with risk of BCS. Large-scale well designed studies are necessary to be conducted to further confirm or refute the observed association.

9 July 2016 in Phlebology: The Journal of Venous Disease
Verified
Journal Article
Closed access
QGQuangen Gao
Quangen Gao
PZPeijin Zhang
Peijin Zhang
WWWei Wang
Wei Wang
HMHe Ma
He Ma
YTYue Tong
Yue Tong
ZLZhaojun Lu
Zhaojun Lu
Objective: Venous thromboembolism is a common complex disorder, being the resultant of gene–gene and gene–environment interactions. Tumor necrosis factor-alpha is a proinflammatory cytokine which has been implicated in venous thromboembolism risk. A promoter 308G/A polymorphism in the tumor necrosis factor-alpha gene has been suggested to modulate the risk for venous thromboembolism. However, the published findings remain inconsistent. Methods: In this study, we conducted a meta-analysis of all available data regarding this issue. Eligible studies were identified through search of Pubmed, EBSCO Medline, Web of Science, and China National Knowledge Infrastructure (CNKI, Chinese) databases up to June 2014. Pooled Odd ratios (ORs) with 95% confidence intervals were applied to estimating the strength of the genetic association in the random-effects model or fixed-effects model. Results: A total of 10 studies involving 1999 venous thromboembolism cases and 2166 controls were included in this meta-analysis to evaluate the association between tumor necrosis factor-alpha-308G/A polymorphism and venous thromboembolism risk. Overall, no significantly increased risk venous thromboembolism was observed in all comparison models when all studies were pooled into the meta-analysis. However, in stratified analyses by ethnicity, there was a pronounced association with venous thromboembolism risk among West Asians in three genetic models (A vs. G: OR = 1.82, 95%CI = 1.13–2.94; GA vs. GG: OR = 1.82, 95%CI = 1.08–3.06; AA/GA vs. GG: OR = 1.88, 95%CI = 1.12–3.16). When stratifying by source of controls, no significant result was detected in all genetic models. Conclusion: This meta-analysis demonstrates that tumor necrosis factor-alpha 308G/A polymorphism may contribute to susceptibility to venous thromboembolism among West Asians. Studies are needed to ascertain these findings in larger samples and different racial groups.

1 October 2015 in Clinics and Research in Hepatology and Gastroenterology
Verified
Journal Article
Closed access
XGXiuyin Gao
Xiuyin Gao
EGEr Gui
Er Gui
ZLZhaojun Lu
Zhaojun Lu
XNXin Ning
Xin Ning
MZMaoheng Zu
Maoheng Zu
GSGuixiang Sun
Guixiang Sun

18 October 2015 in Gastroenterology Research and Practice
Verified
Journal Article
Open access
PDF file
PZPeijin Zhang
Peijin Zhang
YZYanyan Zhang
Yanyan Zhang
JZJing Zhang
Jing Zhang
HWHui Wang
Hui Wang
HMHe Ma
He Ma
ZLZhaojun Lu
Zhaojun Lu
Myeloproliferative neoplasms (MPNs) are the leading cause of Budd-Chiari syndrome (BCS), and the C allele of JAK2 rs4495487 was reported to be an additional candidate locus that contributed to MPNs. In the present study, we examined the role of JAK2 rs4495487 in the etiology and clinical presentation of Chinese BCS patients. 300 primary BCS patients and 311 healthy controls were enrolled to evaluate the association between JAK2 rs4495487 polymorphism and risk of BCS. All subjects were detected for JAK2 rs4495487 by real-time PCR.Results. The JAK2 rs4495487 polymorphism was associated with JAK2 V617F-positive BCS patients compared with controls (P<0.01). The CC genotype increased the risk of BCS in patients with JAK2 V617F mutation compared with individuals presenting TT genotype (OR = 13.60, 95% CI = 2.04–90.79) and non-CC genotype (OR = 12.00, 95% CI = 2.07–69.52). We also observed a significantly elevated risk of combined-type BCS associated with CC genotype in the recessive model (OR = 4.44, 95% CI = 1.31–15.12). This study provides statistical evidence that the JAK2 rs4495487 polymorphism is susceptibility factor JAK2 V617F positive BCS and combined BCS in China. Further larger studies are required to confirm these findings.